Jazz Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Jazz Pharmaceuticals names 13 peer companies for pay. Pay versus performance data of Jazz Pharmaceuticals for that year is not on file, so it has no rank.

Pay peer group, FY2025 (Dec) proxy

Exelixis
Incyte
Gilead Sciences
Biomarin Pharmaceutical
Moderna
United Therapeutics
Alnylam Pharmaceuticals
Alkermes plc.
Regeneron Pharmaceuticals
Neurocrine Biosciences
BiogenNot disclosedNot disclosed
Organon & Co.Not disclosedNot disclosed
Vertex Pharmaceuticals IncorporatedNot disclosedNot disclosed
13 companies

Changes by year

FY2025 (Dec) proxy

  • RemovedHorizon Therapeutics plcpay peer groupbecause they were previously acquired in 2023
  • RemovedSeagen, Inc.pay peer groupbecause they were previously acquired in 2023

FY2023 (Dec) proxy

  • AddedGilead Sciencespay peer group
  • AddedOrganon & Copay peer group
  • RemovedAlexion Pharmaceuticals, Inc.pay peer group
  • RemovedIonis Pharmaceuticalspay peer group
  • RemovedSarepta Therapeutics, Inc.pay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.